Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Ublituximab (Anti-CD20) For research use only.
Not for use in humans.

Ublituximab (Anti-CD20)

Synonyms: LFB-R603; TG-1101; TGTX-1101

Ublituximab (Anti-CD20) is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity.  MW : 145.22 KD.

Ublituximab (Anti-CD20)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ublituximab (Anti-CD20) is a chimeric recombinant IgG1 monoclonal antibody directed against human CD20 with potential antineoplastic activity.  MW : 145.22 KD.

Product Details

CAS No. 1174014-05-1
Molecular Weight 144.5
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ublituximab (Anti-CD20) | Ublituximab (Anti-CD20) supplier | purchase Ublituximab (Anti-CD20) | Ublituximab (Anti-CD20) cost | Ublituximab (Anti-CD20) manufacturer | order Ublituximab (Anti-CD20) | Ublituximab (Anti-CD20) distributor